NASDAQ:LBPS 4D pharma (LBPS) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free LBPS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.65▼$1.6550-Day Range$1.56▼$3.4052-Week Range$1.50▼$11.09VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get 4D pharma alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About 4D pharma4D pharma plc, together with its subsidiaries, develops live biotherapeutic products (LBPs) in the United Kingdom. The company develops therapeutic candidates, including MRx0518 for the treatment of cancer and immune-oncology diseases; MRx-4DP0004 for the treatment of asthma; MRx0029 and MRx0005 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn's disease. It also develops products candidates, such as MRx1299 for solid tumors, MRx0006 for rheumatoid arthritis, and MRx0002 for multiple sclerosis. In addition, the company develops MicroRx platform to discover new LBP candidates for major diseases. 4D pharma plc has a collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate MRx0518; strategic collaboration agreement with University of Texas MD Anderson for discovery and development of LBPs in oncology; and Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda, MRx0518 in patients with solid tumors, and to discover and develop LBPs for vaccines. The company was formerly known as Schosween 18 Limited. 4D pharma plc was incorporated in 2014 and is headquartered in Leeds, the United Kingdom.Read More Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry LBPS Stock News HeadlinesApril 15, 2024 | msn.com4D Molecular Therapeutics new overweight at Barclays on genetic medicine platformApril 8, 2024 | msn.comLancashire: pharmacy robots speed up prescription pickingApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.March 30, 2024 | yahoo.comPROGRESS 2024: In business for more than 60 years, Professional Pharmacy offers a wide range of servicesMarch 18, 2024 | msn.comNAT-STORY4D-Pharmacy first scheme could free up 30 million GP appointments annuallyFebruary 13, 2024 | markets.businessinsider.comStrong Buy Recommendation for 4D Molecular Therapeutics Amid Promising 4D-150 Gene Therapy Study ResultsFebruary 8, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), BridgeBio Pharma (BBIO) and Phibro Animal Health (PAHC)February 5, 2024 | markets.businessinsider.comBuy Rating for 4D Molecular Therapeutics Backed by Promising 4D-150 Gene Therapy Trial ResultsApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.February 5, 2024 | marketwatch.com4D Molecular Therapeutics Shares Rise 33% After Positive Trial DataNovember 9, 2023 | msn.com4D Molecular Therapeutics GAAP EPS of -$0.24 beats by $0.37, revenue of $20.2M beats by $10.98MAugust 9, 2023 | msn.com4D Molecular Therapeutics GAAP EPS of -$0.77 misses by $0.01, revenue of $0.24M misses by $0.78MJuly 14, 2023 | benzinga.comHuman Microbiome Market worth $1.7 billion by 2029May 6, 2023 | benzinga.comThe 4D Bioprinting Market is anticipated to grow at a CAGR of around 35% by 2035, claims Roots AnalysisMay 4, 2023 | msn.com4D Molecular Therapeutics proposes $100M stock offeringMarch 15, 2023 | msn.com4D Molecular Therapeutics, Inc. (FDMT) Reports Q4 Loss, Lags Revenue EstimatesFebruary 7, 2023 | finance.yahoo.comHuman Microbiome Market Report 2023-2033December 15, 2022 | msn.comHow Is The Market Feeling About 4D Molecular Therapeutics?November 18, 2022 | markets.businessinsider.comExpert Ratings for 4D Molecular TherapeuticsOctober 4, 2022 | benzinga.comMicrobiome Therapeutics Market to Boom at Robust CAGR to Cross USD 746 Million by 2028 | BlueWeave ConsultingSeptember 20, 2022 | seekingalpha.comX4 Pharmaceuticals: Upcoming CatalystsJune 28, 2022 | seekingalpha.com4D pharma stock to be delisted from Nasdaq after co was placed into administrationJune 28, 2022 | finance.yahoo.com4D pharma plc ("4D pharma") Receives Notice of Delisting From NasdaqMay 26, 2022 | finance.yahoo.com4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual MeetingMay 19, 2022 | finance.yahoo.com4D pharma to Present at the H.C. Wainwright Global Investment ConferenceMay 17, 2022 | marketwatch.com4D pharma Shares Rise on Encouraging Results From Asthma Treatment TrialMay 17, 2022 | nasdaq.com4D Pharma Presents Data Supporting Potential Of MRx-4DP0004 As Oral Treatment For AsthmaSee More Headlines Receive LBPS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 4D pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:LBPS CUSIPN/A CIK1830162 Webwww.4dpharmaplc.com Phone44-0-11-3895-0130FaxN/AEmployees92Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$720,000.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Duncan Joseph Peyton (Age 52)CEO & Exec. Director Comp: $302.79kDr. Alexander James Stevenson Ph.D. (Age 50)Chief Scientific Officer & Exec. Director Comp: $259.88kMr. John Brendan Doyle (Age 44)Chief Financial Officer Ms. Fay WestonHead of Investor RelationsMr. Adrian MurrayGen. Counsel (Interim)Mr. Glenn DouradoExec. VP of Corp. Devel.Ms. Lucy ChristieVP of HRMr. Christophe CariteSr. VP of CMC & Process Devel.Ms. Imke MulderExec. VP of ResearchMore ExecutivesKey CompetitorsContext TherapeuticsNASDAQ:CNTXGrifolsNASDAQ:GRFSLAVA TherapeuticsNASDAQ:LVTXNLS PharmaceuticsNASDAQ:NLSPPharvarisNASDAQ:PHVSView All Competitors This page (NASDAQ:LBPS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
